Which is the Ideal JAK Inhibitor for Alopecia Areata – Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib ‑ Revisiting the Immunomechanisms of the JAK Pathway.

Autor:	Sardana, Kabir1,2 kabirijdvl@gmail.com, Bathula, Savitha1,2, Khurana, Ananta1,2
Zdroj:	Indian Dermatology Online Journal. Jul/Aug2023, Vol. 14 Issue 4, p465-474. 10p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu